| NOBEL Pharma Schweiz AG - Deferasirox NOBEL 180 mg, Filmtabletten | | 67681 | | 02 | | Deferasirox NOBEL 180 mg | | Filmtabletten | | V03AC03 | | Deferasirox | | 24.08.2020 | | |
| | Composition | | deferasiroxum 180 mg, cellulosum microcristallinum, crospovidonum, povidonum K 30, poloxamerum 188, silica colloidalis anhydrica, magnesii stearas, Überzug: crospovidonum, poly(alcohol vinylicus), macrogolum, talcum, E 171, E 132, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Deferasirox | 180 mg |
| | BAG: Active Agent | Dose |
|---|
| Deferasirox | 180 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Cellulosum Microcristallinum | | | | Crospovidonum | | Überzug | | E 132 | | color. | | E 171 | | color. | | Macrogol | | | | Magnesii Stearas | | | | Poloxamer | 188 | | | Poly(Alcohol Vinylicus) | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
